Finance

Lists
Why is LEGN down ၃.၈၈%?
Dive Deeper
LEGN:NASDAQ
Legend Biotech Corp
၁၈.၅၇ US$
-၃.၈၈%
(-၀.၇၅) 1D
၁၈.၆၂ US$
+၀.၂၇% (+၀.၀၅၀)
After hours
Closed: အောက် ၂, GMT-၄ ၁၆:၀၀:၀၁  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for LEGN...
Open
၁၉.၃၅ US$
High
၁၉.၆၄ US$
Low
၁၈.၅၂ US$
Mkt. cap
၃၆၁.၁၆ ဋေ
Avg. vol.
၂.၀၆ သန်း
Volume
၂.၅၃ သန်း
52-wk high
၃၇.၄၆ US$
52-wk low
၁၆.၂၅ US$
EPS
-၀.၅၀ US$
Beta
၀.၅၇
Shares outstanding
၁၉.၄၅ ကုဋေ
No. of employees
၃ ထောင်
Open
၁၉.၃၅ US$
High
၁၉.၆၄ US$
Low
၁၈.၅၂ US$
Mkt. cap
၃၆၁.၁၆ ဋေ
Avg. vol.
၂.၀၆ သန်း
Volume
၂.၅၃ သန်း
52-wk high
၃၇.၄၆ US$
52-wk low
၁၆.၂၅ US$
EPS
-၀.၅၀ US$
Beta
၀.၅၇
Shares outstanding
၁၉.၄၅ ကုဋေ
No. of employees
၃ ထောင်
News stories
From web sources and news partners
Kalkine Media
Kalkine Media
·
ပြီးခဲ့သည့် ၂ ရက်
Legend Biotech Director Corazon Sanders Sells 27,370 Shares at $9.46 Average Price
The Globe and Mail
The Globe and Mail
·
ပြီးခဲ့သည့် ၅ ရက်
Analysts Are Bullish on These Healthcare Stocks: Legend Biotech (LEGN), Ocugen (OCGN)
About Legend Biotech Corp
CEO-
Employees၃.၂ ထောင်
Founded၂၀၁၄ နို ၁၇
HeadquartersSomerset, နယူးဂျာစီပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Analyst ratings
Based on 9 analysts giving stock ratings to LEGN in the past 3 months
Buy
Buy
5
Hold
4
Sell
0
12-month forecast
Based on 9 Wall Street analysts offering 12 month price targets for LEGN in the last 3 months.
Highest
Current ၁၈.၅၇ US$
၇၄.၀၀ US$ (+၂၉၈.၄၉%)
Average
၄၅.၄၁ US$ (+၁၄၄.၅၃%)
Lowest
၂၄.၀၀ US$ (+၂၉.၂၄%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ashwani Verma
UBS
Hold
Reiterated
၂၄.၀၀ US$
+၂၉.၂%
10/02/2026
Mitchell Kapoor
H.C. Wainwright
Buy
Reiterated
၆၅.၀၀ US$
+၂၅၀%
09/30/2026
Etzer Darout
Barclays
Buy
Maintained
၇၄.၀၀ US$
+၂၉၈.၅%
09/11/2026
Leonid Timashev
RBC Capital
Buy
Maintained
၅၈.၀၀ US$
+၂၁၂.၃%
09/09/2026
Terence Flynn
Morgan Stanley
Buy
Maintained
၄၈.၀၀ US$
+၁၅၈.၅%
08/12/2026
Ziyi Chen
Goldman Sachs
Buy
Maintained
၄၀.၇၀ US$
+၁၁၉.၂%
08/12/2026
Kostas Biliouris
Oppenheimer
Hold
Downgraded
၄၀.၀၀ US$
+၁၁၅.၄%
08/12/2026
Yaron Werber
TD Cowen
Hold
Reiterated
၂၄.၀၀ US$
+၂၉.၂%
08/12/2026
Jessica Fye
J.P. Morgan
Hold
Initiated
၃၅.၀၀ US$
+၈၈.၅%
07/13/2026
Edward Tenthoff
Piper Sandler
Buy
Reiterated
၆၄.၀၀ US$
+၂၄၄.၆%
06/15/2026
Asthika Goonewardene
Truist Financial
Buy
Maintained
၇၀.၀၀ US$
+၂၇၇%
03/13/2026
James Shin
Deutsche Bank
Buy
Reiterated
၆၀.၀၀ US$
+၂၂၃.၁%
03/09/2026
Qize Ding
Rothschild & Co Redburn
Hold
Downgraded
၂၄.၀၀ US$
+၂၉.၂%
02/12/2026
Last report
၂၀၂၆ ဩ ၁၁
Fiscal period
Q2 2026
EPS / Est. (USD)
၀.၃၂ US$ / ၀.၂၈ US$
+၁၄.၂၉%beat
Revenue / Est. (USD)
၃၈.၇၅ ကုဋေ / ၃၅.၁၇ ကုဋေ
+၁၀.၁၆%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
၂၇.၂၃ ကုဋေ
၃၀.၆၄ ကုဋေ
၃၀.၅၁ ကုဋေ
၃၈.၇၅ ကုဋေ
Cost of goods sold
၁၁.၅၃ ကုဋေ
၁၂.၃၅ ကုဋေ
၁၇.၅၉ ကုဋေ
၁၃.၇၄ ကုဋေ
Cost of revenue
၁၁.၅၃ ကုဋေ
၁၂.၃၅ ကုဋေ
၁၇.၅၉ ကုဋေ
၁၃.၇၄ ကုဋေ
Research and development expenses
၁၁.၃၁ ကုဋေ
၁၀.၁၃ ကုဋေ
၈.၅၇ ကုဋေ
၉.၆၀ ကုဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၈.၇၃ ကုဋေ
၁၀.၁၂ ကုဋေ
၉.၀၁ ကုဋေ
၉.၆၄ ကုဋေ
Operating expense
၂၀.၀၅ ကုဋေ
၂၀.၃၅ ကုဋေ
၁၇.၉၀ ကုဋေ
၁၉.၂၄ ကုဋေ
Total operating expenses
၃၁.၅၈ ကုဋေ
၃၂.၇၀ ကုဋေ
၃၅.၄၉ ကုဋေ
၃၂.၉၈ ကုဋေ
Operating income
-၄.၃၅ ကုဋေ
-၂.၀၆ ကုဋေ
-၄.၉၈ ကုဋေ
၅.၇၇ ကုဋေ
Other non operating income
-၆.၅၄ သိန်း
၃.၂၉ သန်း
-၅.၀၀ သိန်း
-၁.၄၀ သန်း
EBT including unusual items
-၃.၉၁ ကုဋေ
-၁.၉၆ ကုဋေ
-၅.၃၁ ကုဋေ
၅.၅၅ ကုဋေ
EBT excluding unusual items
-၃.၉၁ ကုဋေ
-၂.၀၆ ကုဋေ
-၅.၃၁ ကုဋေ
၅.၅၅ ကုဋေ
Income tax expense
၆.၁၆ သိန်း
၁.၁၂ ကုဋေ
၁.၂၀ သန်း
၂.၂၃ ကုဋေ
Effective tax rate
-၁.၅၈%
-၅၇.၂၃%
-၂.၂၆%
၄၀.၁၈%
Other operating expenses
-
၁.၀၀ သန်း
၃.၂၀ သန်း
-
Net income
-၃.၉၇ ကုဋေ
-၃.၀၈ ကုဋေ
-၅.၄၃ ကုဋေ
၃.၃၂ ကုဋေ
Net profit margin
-၁၄.၅၇%
-၁၀.၀၆%
-၁၇.၈၀%
၈.၅၇%
Earnings per share
-၀.၂၂
-၀.၁၆
-၀.၂၈
၀.၃၂
Interest and investment income
၉.၆၆ သန်း
၇.၉၅ သန်း
၇.၃၀ သန်း
၅.၆၀ သန်း
Interest expense
-၄.၅၀ သန်း
-၇.၈၀ သန်း
-၄.၂၀ သန်း
-၃.၉၀ သန်း
Net interest expenses
၅.၁၆ သန်း
၁.၅၀ သိန်း
၃.၁၀ သန်း
၁.၇၀ သန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
-၄.၁၅ ကုဋေ
-၁.၇၉ ကုဋေ
-၄.၇၄ ကုဋေ
၆.၁၇ ကုဋေ
Gain or loss from assets sale
-၂.၅၀ သိန်း
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google အက်ပ်များ